In the current preclinical study, we demonstrate the therapeutic potential of sarcospan (SSPN) overexpression to alleviate cardiomyopathy associated with Duchenne muscular dystrophy (DMD) utilizing dystrophin-deficient mdx mice with utrophin haploinsufficiency that more accurately represent the severe disease course of human DMD. SSPN interacts with dystrophin, the DMD disease gene product, and its autosomal paralog utrophin, which is upregulated in DMD as a partial compensatory mechanism. SSPN-Tg mice have enhanced abundance of fully glycosylated α-dystroglycan, which may further protect dystrophin-deficient cardiac membranes. Baseline echocardiography revealed that SSPN improves systolic function and hypertrophic indices in mdx and mdx:utr-heterozygous mice. Assessment of SSPN-Tg mdx mice by hemodynamic pressure-volume methods highlighted enhanced systolic performance compared with mdx controls. SSPN restored cardiac sarcolemma stability, the primary defect in DMD disease; reduced fibrotic response; and improved contractile function. We demonstrate that SSPN ameliorated more advanced cardiac disease in the context of diminished sarcolemma expression of utrophin and β1D integrin, which mitigate disease severity, and partially restored responsiveness to β-adrenergic stimulation. Overall, our current and previous findings suggest that SSPN overexpression in DMD mouse models positively affects skeletal, pulmonary, and cardiac performance by addressing the stability of proteins at the sarcolemma that protect the heart from injury, supporting SSPN and membrane stabilization as a therapeutic target for DMD.
Michelle S. Parvatiyar, Alexandra J. Brownstein, Rosemeire M. Kanashiro-Takeuchi, Judd R. Collado, Karissa M. Dieseldorff Jones, Jay Gopal, Katherine G. Hammond, Jamie L. Marshall, Abel Ferrel, Aaron M. Beedle, Jeffrey S. Chamberlain, Jose Renato Pinto, Rachelle H. Crosbie
Title and authors | Publication | Year |
---|---|---|
A de novo TNNI3K variant aggravates the pathogenicity of DMD-associated early-onset cardiomyopathy: a case report
Qie D, Zhai Y, Yang F, Li Y, Xu R |
Frontiers in Genetics | 2025 |
The Genetic Factors Influencing Cardiomyopathies and Heart Failure across the Allele Frequency Spectrum.
Mukhopadhyay S, Dixit P, Khanom N, Sanghera G, McGurk KA |
Journal of Cardiovascular Translational Research | 2024 |
The Development of Robust Antibodies to Sarcospan, a Dystrophin- and Integrin-Associated Protein, for Basic and Translational Research
Mokhonova EI, Malik R, Mamsa H, Walker J, Gibbs EM, Crosbie RH |
International journal of molecular sciences | 2024 |
Aging reveals a sex-dependent susceptibility of sarcospan-deficient mice to cardiometabolic disease.
Rahimi Kahmini A, Valera IC, Crawford RQ, Samarah L, Reis G, Elsheikh S, Kanashiro-Takeuchi RM, Mohammadipoor N, Olateju BS, Matthews AR, Parvatiyar MS |
American journal of physiology. Heart and circulatory physiology | 2024 |
FNDC1 is a myokine that promotes myogenesis and muscle regeneration.
Zhang RX, Zhai YY, Ding RR, Huang JH, Shi XC, Liu H, Liu XP, Zhang JF, Lu JF, Zhang Z, Leng XK, Li F, Xiao JY, Xia B, Wu JW |
The EMBO journal | 2024 |
Genome-wide association analysis provides insights into the molecular etiology of dilated cardiomyopathy
Zheng SL, Henry A, Cannie D, Lee M, Miller D, McGurk KA, Bond I, Xu X, Issa H, Francis C, De Marvao A, Theotokis PI, Buchan RJ, Speed D, Abner E, Adams L, Aragam KG, Ärnlöv J, Raja AA, Backman JD, Baksi J, Barton PJ, Biddinger KJ, Boersma E, Brandimarto J, Brunak S, Bundgaard H, Carey DJ, Charron P, Cook JP, Cook SA, Denaxas S, Deleuze JF, Doney AS, Elliott P, Erikstrup C, Esko T, Farber-Eger EH, Finan C, Garnier S, Ghouse J, Giedraitis V, Guðbjartsson DF, Haggerty CM, Halliday BP, Helgadottir A, Hemingway H, Hillege HL, Kardys I, Lind L, Lindgren CM, Lowery BD, Manisty C, Margulies KB, Moon JC, Mordi IR, Morley MP, Morris AD, Morris AP, Morton L, Noursadeghi M, Ostrowski SR, Owens AT, Palmer CN, Pantazis A, Pedersen OB, Prasad SK, Shekhar A, Smelser DT, Srinivasan S, Stefansson K, Sveinbjörnsson G, Syrris P, Tammesoo ML, Tayal U, Teder-Laving M, Thorgeirsson G, Thorsteinsdottir U, Tragante V, Trégouët DA, Treibel TA, Ullum H, Valdes AM, van Setten J, van Vugt M, Veluchamy A, Verschuren WM, Villard E, Yang Y, Asselbergs FW, Cappola TP, Dube MP, Dunn ME, Ellinor PT, Hingorani AD, Lang CC, Samani NJ, Shah SH, Smith JG, Vasan RS, O\u2019Regan DP, Holm H, Noseda M, Wells Q, Ware JS, Lumbers RT |
Nature Genetics | 2024 |
Modification-specific Proteomic Analysis Reveals Cysteine S-Palmitoylation Involved in Esophageal Cancer Cell Radiation
Ni Q, Pan C, Han G |
ACS Omega | 2024 |
Multi-omics analysis of sarcospan overexpression in mdx skeletal muscle reveals compensatory remodeling of cytoskeleton-matrix interactions that promote mechanotransduction pathways
McCourt JL, Stearns-Reider KM, Mamsa H, Kannan P, Afsharinia MH, Shu C, Gibbs EM, Shin KM, Kurmangaliyev YZ, Schmitt LR, Hansen KC, Crosbie RH |
Skeletal Muscle | 2023 |
High-Throughput Screening to Identify Modulators of Sarcospan.
Shu C, Mokhonova E, Crosbie RH |
Methods in molecular biology (Clifton, N.J.) | 2023 |
Myoscaffolds reveal laminin scarring is detrimental for stem cell function while sarcospan induces compensatory fibrosis.
Stearns-Reider KM, Hicks MR, Hammond KG, Reynolds JC, Maity A, Kurmangaliyev YZ, Chin J, Stieg AZ, Geisse NA, Hohlbauch S, Kaemmer S, Schmitt LR, Pham TT, Yamauchi K, Novitch BG, Wollman R, Hansen KC, Pyle AD, Crosbie RH |
npj Regenerative Medicine | 2023 |
A Brief Review of Duchenne Muscular Dystrophy Treatment Options, with an Emphasis on Two Novel Strategies
Heydemann A, Siemionow M |
Biomedicines | 2023 |
Efficacy of exon-skipping therapy for DMD cardiomyopathy with mutations in actin binding domain 1
Shiba N, Yang X, Sato M, Kadota S, Suzuki Y, Agata M, Nagamine K, Izumi M, Honda Y, Koganehira T, Kobayashi H, Ichimura H, Chuma S, Nakai J, Tohyama S, Fukuda K, Miyazaki D, Nakamura A, Shiba Y |
2023 | |
Extracellular matrix contribution to disease progression and dysfunction in myopathy
Long AM, Lee G, Demonbreun AR, McNally EM |
AJP Cell Physiology | 2023 |
Systemic delivery of large-scale manufactured Wharton’s Jelly mesenchymal stem cell-derived extracellular vesicles improves cardiac function after myocardial infarction
M Bellio, R Kanashiro-Takeuchi, L Takeuchi, S Kulandavelu, Y Lee, W Balkan, K Young, J Hare, A Khan |
2022 | |
The role of the dystrophin glycoprotein complex in muscle cell mechanotransduction.
Wilson DGS, Tinker A, Iskratsch T |
2022 | |
Sperm Transcriptional State Associated with Paternal Transmission of Stress Phenotypes
AM Cunningham, DM Walker, A Ramakrishnan, MA Doyle, RC Bagot, HM Cates, CJ Peña, O Issler, CK Lardner, C Browne, SJ Russo, L Shen, EJ Nestler |
The Journal of neuroscience : the official journal of the Society for Neuroscience | 2021 |
Sarcospan increases laminin-binding capacity of α-dystroglycan to ameliorate DMD independent of Galgt2
H Mamsa, R Stark, K Shin, A Beedle, R Crosbie |
Human Molecular Genetics | 2021 |
Sexual dimorphism in cardiac transcriptome associated with a troponin C murine model of hypertrophic cardiomyopathy
KM Jones, C Vied, IC Valera, PB Chase, MS Parvatiyar, JR Pinto |
Physiological Reports | 2020 |
High-throughput screening identifies modulators of sarcospan that stabilize muscle cells and exhibit activity in the mouse model of Duchenne muscular dystrophy
C Shu, L Parfenova, E Mokhonova, JR Collado, R Damoiseaux, J Campagna, V John, RH Crosbie |
Skeletal Muscle | 2020 |